THE BioMed Co., Ltd. (KOSDAQ:214610)
5,750.00
-200.00 (-3.36%)
At close: Jun 13, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Biochemical Diagnosis | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biochemical Diagnosis Growth | 56.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Molecular Diagnosis | 1.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Molecular Diagnosis Growth | -71.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Immunity Diagnosis | 413.86M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Immunity Diagnosis Growth | -94.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 36.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 36.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Other | 2.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -67.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 2.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -68.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 771.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -61.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 120.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | -24.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 2.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -67.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|